| ISSN |
2220-3230 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sophia Hatzianastasiou, Paraskevas Vlachos, Georgios Stravopodis, Dimitrios Elaiopoulos, Afentra Koukousli, Josef Papaparaskevas, Themistoklis Chamogeorgakis, Kyrillos Papadopoulos, Theodora Soulele, Despoina Chilidou, Kyriaki Kolovou, Aggeliki Gkouziouta, Michail Bonios, Stamatios Adamopoulos and Stavros Dimopoulos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Stavros Dimopoulos, MD, PhD, Chief Doctor, Director, Director, Heart Transplantation Unit, Onassis Cardiac Surgery Center, 356 Syggrou Av, Athens 17674, Greece. stdimop@gmail.com |
| Key Words |
Heart transplantation; Multi drug resistant organisms; Transplantation complications; Transplantation outcome |
| Core Tip |
We evaluated multidrug-resistant organisms (MDROs) in heart transplantation and their impact on patient outcome. Carbapenem-resistant Gram-negative bacteria predominated, in line with the epidemiologic pattern in south-eastern Europe. Among comorbidities, renal failure and higher body mass index were shown to be important risk factors pre-transplantation. Surgical and medical complications were shown to be predictive of MDRO acquisition, while no association was shown for the type of cardiomyopathy, for the mode of admission [from home, ward or intensive care unit (ICU)] or for previous cardiac surgery. MDRO presence was associated with longer ICU and hospital length of stay, and higher ICU-mortality and 1-year mortality. |
| Publish Date |
2024-06-14 08:01 |
| Citation |
<p>Hatzianastasiou S, Vlachos P, Stravopodis G, Elaiopoulos D, Koukousli A, Papaparaskevas J, Chamogeorgakis T, Papadopoulos K, Soulele T, Chilidou D, Kolovou K, Gkouziouta A, Bonios M, Adamopoulos S, Dimopoulos S. Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation. <i>World J Transplant</i> 2024; 14(2): 93567</p> |
| URL |
https://www.wjgnet.com/2220-3230/full/v14/i2/93567.htm |
| DOI |
https://dx.doi.org/10.5500/wjt.v14.i2.93567 |
